FG Merger II (NASDAQ:FGMC – Get Free Report) and OSR (NASDAQ:OSRH – Get Free Report) are both small-cap financial services companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, profitability, institutional ownership and dividends.
Insider & Institutional Ownership
55.3% of OSR shares are held by institutional investors. 20.2% of FG Merger II shares are held by insiders. Comparatively, 36.8% of OSR shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Risk and Volatility
FG Merger II has a beta of 0.07, suggesting that its share price is 93% less volatile than the S&P 500. Comparatively, OSR has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| FG Merger II | N/A | 597.61% | 1.69% |
| OSR | -363.26% | -7.24% | -5.41% |
Valuation & Earnings
This table compares FG Merger II and OSR”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| FG Merger II | N/A | N/A | $1.43 million | $0.01 | 1,046.00 |
| OSR | $2.91 million | 4.60 | -$27.06 million | ($0.33) | -1.15 |
FG Merger II has higher earnings, but lower revenue than OSR. OSR is trading at a lower price-to-earnings ratio than FG Merger II, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent ratings and price targets for FG Merger II and OSR, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| FG Merger II | 1 | 0 | 0 | 0 | 1.00 |
| OSR | 1 | 0 | 0 | 0 | 1.00 |
Summary
FG Merger II beats OSR on 6 of the 10 factors compared between the two stocks.
About FG Merger II
FG Merger II Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on September 20, 2023 and is headquartered in Itasca, IL.
About OSR
OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D “platform technologies” versus “assets only” companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.
Receive News & Ratings for FG Merger II Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FG Merger II and related companies with MarketBeat.com's FREE daily email newsletter.
